KAVRETH Trademark

Trademark Overview

On Tuesday, November 11, 2014, a trademark application was filed for KAVRETH with the United States Patent and Trademark Office. The USPTO has given the KAVRETH trademark a serial number of 86450979. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 12, 2024. This trademark is owned by Glaxo Group Limited. The KAVRETH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
kavreth

General Information

Serial Number86450979
Word MarkKAVRETH
Filing DateTuesday, November 11, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 12, 2024
Registration Number5367146
Registration DateTuesday, January 2, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Wednesday, April 8, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 14, 2014NEW APPLICATION ENTERED
Wednesday, November 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Monday, March 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 20, 2015ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, March 24, 2015ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, April 28, 2015PUBLISHED FOR OPPOSITION
Tuesday, April 28, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, July 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 23, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 18, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, November 18, 2015SOU EXTENSION 1 FILED
Wednesday, November 18, 2015SOU EXTENSION 1 GRANTED
Friday, November 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, May 31, 2016SOU EXTENSION 2 FILED
Friday, July 1, 2016SOU EXTENSION 2 GRANTED
Friday, July 1, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 6, 2016SOU TEAS EXTENSION RECEIVED
Thursday, June 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 8, 2017TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, November 8, 2017NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 6, 2016SOU EXTENSION 3 FILED
Sunday, December 18, 2016SOU EXTENSION 3 GRANTED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, June 13, 2017SOU EXTENSION 4 FILED
Tuesday, June 13, 2017SOU EXTENSION 4 GRANTED
Wednesday, November 29, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, January 2, 2018REGISTERED-PRINCIPAL REGISTER
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 2, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 12, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

kavreth pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological